Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SWK Holdings Corp SWKH

Alternate Symbol(s):  SWKHL

Financial Services
SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash... see more

Recent & Breaking News (NDAQ:SWKH)

Enteris BioPharma Announces Dr. John Vrettos to Host Webinar on Advances in Oral Delivery of Peptide Therapeutics

PR Newswire September 15, 2020

Enteris BioPharma to Participate in BioPharm America's Drug Delivery Partnerships 2020 Conference

PR Newswire September 9, 2020

SWK Holdings to Participate in 2020 Colliers Institutional Investor Conference

PR Newswire September 9, 2020

PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties to SWK Holdings Corporation

PR Newswire August 31, 2020

SWK Holdings Corporation Announces Financial Results for Second Quarter 2020

PR Newswire August 17, 2020

SWK Holdings to Report Second Quarter 2020 Financial Results

PR Newswire August 14, 2020

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

GlobeNewswire June 29, 2020

SWK Holdings Corporation Added to Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index

PR Newswire June 29, 2020

SWK Holdings to Webcast Live at Life Sciences Investor Forum

PR Newswire June 23, 2020

Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020

GlobeNewswire June 23, 2020

Enteris BioPharma Announces Dr. John Vrettos to Participate in BIODURO Webinar Series

PR Newswire June 9, 2020

Enteris BioPharma to Participate in BIO International Digital Convention

PR Newswire June 2, 2020

SWK Holdings Corporation Announces Financial Results for First Quarter 2020

PR Newswire May 14, 2020

Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer

PR Newswire May 4, 2020

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2019

PR Newswire March 30, 2020

SWK Holdings Corporation Announces Reauthorization of Share Repurchase Program and Provides Business Update on Coronavirus (COVID-19) Impact

PR Newswire March 26, 2020

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

PR Newswire February 28, 2020

Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer

PR Newswire February 10, 2020

Enteris BioPharma Receives 2019 Best of Boonton Award

PR Newswire January 27, 2020

SWK Holdings Corporation Announces Commencement of Trading on the Nasdaq Capital Market

PR Newswire January 23, 2020